2. Academic Validation
  3. Benzyl prolinate derivatives as novel selective KCC2 blockers

Benzyl prolinate derivatives as novel selective KCC2 blockers

  • Bioorg Med Chem Lett. 2010 Apr 15;20(8):2542-5. doi: 10.1016/j.bmcl.2010.02.092.
Cécile Pégurier 1,  Nathalie Bosman,  Philippe Collart,  Marie-Laure Delporte,  Karine Leclercq,  Sébastien Lengelé,  Ananda Kumar Kanduluru,  Stéphane Meunier,  Nathalie Pacico,  Lakshmana Rao Vadali,  Alain Wagner,  Christian Wolff,  Laurent Provins
Affiliations

Affiliation

  • 1 UCB Pharma SA, UCB NewMedicines, Chemin du Foriest, B-1420 Braine-L'Alleud, Belgium.
PMID: 20299216 DOI: 10.1016/j.bmcl.2010.02.092
Abstract

The discovery and optimization of a novel class of selective submicromolar KCC2 blockers is described. Details of synthesis and SAR are given together with ADME properties of selected compounds. A methylsulfone residue on the R(1) phenyl group improved the overall general profile of these prolinate derivatives.

Figures
Products